1.
OA06.05 Impact of COVID-19 Pandemic on Proportion and Treatment Patterns for Stage I Non-small Cell Lung Cancer in the Netherlands
55P Real-world monitoring of hybrid dosing of pembrolizumab in stage IV non-small cell lung cancer in the Netherlands
The Dutch Lung Cancer Audit: Nationwide quality of care evaluation of lung cancer patients
2.
3.
